8-K/A

AMENDMENT TO FILED CURRENT REPORT

Company: RELMADA THERAPEUTICS, INC.
Filed: April 6, 2020
Period of Report: March 6, 2020
Accession Number: 0001213900-20-008650

View Document ↗ View on SEC.gov ↗